Mouse interferon preparations enhanced the specific cytotoxicity of sensitized lymphocytes for allogeneic target tumor cells. The factor responsible for the enhancement of cytotoxicity could not be dissociated from the antiviral activity of interferon by standard physicochemical means. Thus, in addition to its well-known antiviral activity, and its effect on cell division, interferon also appears to enhance a specialized cellular function. It is suggested that a common mechanism of action underlies these seemingly different biologic phenomena, and that interferon may play a role in the regulation of fundamental cellular processes.
In addition to its well-known antiviral activity, interferon has been shown to inhibit the multiplication of tumor and normal'mammalian cells in culture (1) (2) (3) (4) . It seems likely, therefore, that the antiviral action of interferon is only one expression of the effect of interferon on cells (3, 4) . In the course of our studies on interferon-cell interactions, we observed that prior treatment of sensitized splenic lymphocytes with interferon resulted in an enhancement of the specific cytotoxicity of these cells for target tumor cells. Thus, interferon appears to enhance a specialized cellular function. The results of these experiments and the evidence suggesting that interferon was the factor responsible for enhancement of cytotoxicity of sensitized lymphocytes for target tumor cells are presented herein.
MATERIALS AND METHODS
Immunization of Mice with L 1210 Cells. Mouse lymphoid leukemia L 1210 cells (5) were maintained by serial passage in ascitic form in DBA/2 mice. For immunization, C 57 BL/6 mice were injected intraperitoneally with 5 X 107 L 1210 cells. The spleens of immunized mice were usually harvested 10 days after injection.
Lymphocytes. Suspensions of splenic lymphocytes from immunized or normal C 57 BL/6 mice were obtained according to the method of Brunner et al. (6) . The washed lymphocytes were suspended in Eagle's medium containing 10% heatinactivated calf serum -at a density of 20 X 106 viable' cells per ml.
Target Cells. L 1210 cells, an interferon resistant subline of L 1210 cells (7) (L 1210-R) and Ehrlich ascites cells (7) were grown in nonagitated suspension cultures in nutrient medium RPMI 1640 (Gibco), supplemented with 10% heatAbbreviation: NDV, Newcastle Disease Virus. 721 inactivated horse serum, 1% iL-glutamine (10 mM/ml), penicillin (200 U/ml), and streptomycin (40 pg/ml). For labeling with radioactive chromium (51Cr), 1 ml of a cell suspension (5 X 106 viable cells per ml) was incubated for 30 min at 37°with 0.1 ml of Na251CrO4 (200 uCi/ml, specific activity 400 mCi/mg of chromium, Centre d'Energie Atomique, France), according to the method of Brunner et al. (6, 8) . The cell suspensions were washed three times and readjusted to a density of 2 X 106 viable cells per ml.
Interferon and Control Preparations. Mouse interferon preparations were obtained from the nutrient medium of monolayer cultures of MSV-Ia (9), L-929 (10) , and L cells (11, 12 ) that were inoculated with ultraviolet light-inac'tivated Newcastle Disease virus (NDV), and from the brains of IC (Institut du Cancer) and C 57 BL/6 mice that were inoculated intracerebrally with West Nile virus (13) . Human interferon preparations (generously provided by Dr. C. Chany) were derived from the nutrient medium of leucocyte suspensions inoculated with NDV (14) . Rabbit interferon preparations were obtained from the sera of rabbits inoculated with NDV (15) . Control preparations consisted of the medium of uninoculated cell cultures or tissues of uninoculated animals. All interferon and control preparations were treated at pH 2 for 18 hr (preparations containing West Nile virus), or 6 days (preparations containing NDV), centrifuged at 30,000 rpm (60,000 X g) for 1 hr in a Martin Christ centrifuge, Omega, and then concentrated 10-fold by forced dialysis. MSV-Ia and mouse brain interferon were purified by filtration through a Sephadex G-75 column (16) . I929 interferon (generously provided by Dr. G. Bodo) was concentrated with zinc acetate, 0.02 M at pH 7.2, dissolved at pH 2.5, chromatographed on sulfoethyl-Sephadex C-25, concentrated, and freeze-dried or further purified by chromatography on DEAE-cellulose and carboxymethyl-Sephadex C-25 (10) . I-cell interferon (generously provided by Dr. K. Paucker) was purified by electrophoresis (11, 12) .
Mouse, human, and rabbit interferon preparations were assayed on monolayer cultures of mouse I-, monkey BSC-, and rabbit RK13-cells, respectively. One mouse interferon unit (as expressed in the text) equals 4 fications. The medium consisted of Eagle's medium supplemented with 10% heat-inactivated calf serum. Spleen-cell suspensions containing 2 X 107 or less cells per ml were mixed with equal volumes of 5"Cr-labeled target-cell suspensions containing 2 X 106 cells per ml; 0.25 ml of the reaction mixtures were placed in disposable hemolysis tubes (13 X 75 mm) , and incubated at 370 during the indicated period of time.
For each reaction mixture, 6 or 10 identical tubes were used. For assay of "Cr released, 1.75 ml of phosphate buffered saline (PBS) was added to each tube, followed by centrifugation at 1500 rpm (800 X g) for 5 min. The effect of interferon on the cytotoxicity of sensitized lymphocytes was determined by incubation of lymphocytes with a 1:10 volume of interferon, control preparation, or nutrient medium at 370 for the specified period of time before addition of target cells (see Figs. 1-3) . Unless stated otherwise, interferon or control preparations were present in the reaction mixture throughout the experiment.
RESULTS
Effect of interferon on specific cytotoxicity of sensitized lymphocytes Splenic lymphocytes from C 57 BL/6 mice, immunized with allogeneic L 1210 cells, readily lysed "Cr-labeled L 1210 target cells within 6 hr of incubation (Table 1) . Prior treatment of sensitized lymphocyte suspensions with mouse interferon preparations considerably enhanced this specific cytotoxicity. These results are expressed in Fig. 1 as the percentage of specific chromium release calculated according to the formula described in Methods. Enhancement of the cytotoxicity of sensitized lymphocytes by interferon was observed at lymphocyte: target cell ratios of 30:1, 50:1, and 100:1. For convenience, however, a lymphocyte: target cell ratio of 50:1 was used in the following experiments. The factor in the interferon preparations responsible for the enhancement of specific cytotoxicity fulfilled the various physicochemical criteria that characterize interferon. Thus, prior treatment of these preparations with trypsin or sodium periodate (17) destroyed both the antiviral activity of interferon and the cytotoxicity enhancing activity. Heating at 600 for 1 hr markedly decreased both activities. Ribonuclease and deoxyriboniuclease had no effect on interferon.
Specificity of the interferon-mediated enhancement of cytotoxicity of sensitized lymphocytes
The lysis of allogeneic target cells by sensitized lymphocytes is an immune-specific reaction (8, 18, 19) . The specificity of (3) . However, the enhanced cytotoxicity of sensitized lymphocytes resulted from the effect of interferon on lymphocytes and not from an effect on the target cells: (a) The enhancing effect of interferon on sensitized lymphocytes was also observed when interferon was removed from the suspensions (by washing the lymphocytes) prior to addition of the target cells. The mechanism of specific target-cell lysis mediated by sensitized lymphocytes remains unknown (18, 19) . To our knowledge, there is only one other reported example of an enhancement of cytotoxicity of sensitized lymphocytes. Brunner and his coworkers (19) found that prior treatment of sensitized lymphocytes with specific soluble antigen increased their cytotoxicity. It is of interest that contact between specific antigen and sensitized lymphocytes or target cell and sensitized lymphocytes induces a rapid release of interferon (23, 24) . It is thus possible that the enhancement of cytotoxicity observed by Brunner et al. (19) was in fact mediated by interferon.
The interest in the results presented herein may be 2-fold.
First, if interferon enhances the cytotoxicity of sensitized lymphocytes in vivo as it does in our in vitro experiments, it may help to explain in part the observed efficacy of interferon in the treatment of animals inoculated with viruses (25), protozoa (26) , or transplantable tumors (27, 28) . Second, the enhancement of a specialized cellular function by interferon may not be limited to the system of sensitized lymphocytes that we have investigated, but may be a more general phenomenon. In this regard, Stewart and his coworkers have shown that the "priming" of cells in culture by interferon (which enhances subsequent interferon production after inoculation of an inducer) is an activity distinct from the antiviral activity of interferon (29) . Likewise, Huang and his coworkers have recently shown (30) that mouse interferon preparations enhanced the phagocytosis of colloidal carbon particles by mouse peritoneal macrophages.
Interferon has now been shown to exert varied and seemingly unrelated effects on cells (i.e., inhibition of viral multiplication, inhibition of cell division, and enhancement of specialized cellular function). It seems reasonable to us to suggest that a common mechanism of action underlies these apparently different biologic phenomena, and that interferon plays a role in the regulation of fundamental cellular processes.
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